Humanized monoclonal antibodies against activated protein c and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO RE49099
SERIAL NO

16419319

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are humanized antibodies that selectively bind to and inhibit activated protein C without binding to or inhibiting unactivated protein C. Methods of treatment employing these antibodies are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER HEALTHCARE LLCNEW JERSEY NEW JERSEY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Ji-Yun Berkeley, US 21 89
Tebbe, Jan Cologne, DE 27 154
Wang, Zhuozhi Millbrae, US 39 104
Zhao, Xiao-Yan Union City, US 9 15
Zhu, Ying Alamo, US 84 1432

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 7, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 7, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 7, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00